Infection 2025
27-28 October 2025,
ICC Birmingham, UK
Welcome to the BSAC’s Winter Conference 2025
Antimicrobial resistance is the greatest healthcare challenge of our time—be part of the solution. The BSAC’s Infection 2025 conference was held at The International Convention Centre (ICC) in Birmingham on 27 & 28 October. Explore cutting-edge research, connect with global experts, and help shape the future of our response to this global health emergency.
The recorded content is now available below.
This conference is RCPath CPD approved (11 credits).
For all enquiries, please contact Esme Carruthers
You can view the posters from this conference using the link below:
Access posters
Programme
SESSION ONE: Funding the fight against superbugs - how do antimicrobials survive the perfect storm?
-
The video of this session includes the following presentations:
Welcome and opening remarks - Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC
AMR R&D in Numbers: Tracking Global Progress and Gaps - Dr Lesley Ann Ogilvie, Global AMR R&D Hub
Is anything working? PPP, push pull and non profit funding incentives - Will Hall, Director of External Affairs, CARB-X
The UK subscription model - moonshot or replicable - Dr Michael Anderson, University of Manchester
Q&A
SESSION TWO: Invited lecture
-
The video of this session includes the following presentations:
RSV in children, adults and older adults: The silent burden - Professor Harish Nair, University of Edinburgh
Q&A
SESSION THREE: On the Wards and In the Lab: Clinical-Pathological Conundrums- making the lab-clinic connection tangible and exciting
-
The video of this session includes the following presentations:
When the dust settles: diagnosing the unexpected - Dr Amy Carroll, Barts Health NHS Trust
Beyond the Differential: How the Lab Unmasked a Re-emerging Threat - Melissa Prior-Ong, Torbay and South Devon NHS Foundation Trust
Heart of the Matter: Navigating Complexities in Endocarditis - Dr Niamh Reidy, Clinical Fellow in Microbiology, UCLH
Q&A
SESSION FIVE: Fireside discussion: BSAC Resistance Surveillance Project, contributions to the infection community
-
The video of this session includes the following presentations:
Panellists:
Professor Alasdair MacGowan, North Bristol NHS Trust
Professor David Livermore, Retired Professor of Medical Microbiology, University of East Anglia
Dr Ben Parcell, University of Dundee
SESSION SIX: Publishing and editorial insights
-
The video of this session includes the following presentations:
What editors really want! How to get published - Dr Vicky Enne, Ellison Institute of Technology & Honorary Senior Research Fellow, UCL
From poster to paper - it's easier than you think! - Neil Powell, Royal Cornwall Hospitals NHS Trust
Yes you can: Engaging with an academic journal - how to do it and what’s in it for you! - Professor Paul Long, King's College London
Q&A
SESSION SEVEN: Protect me at all cost! The impact of antimicrobials on the microbiome
-
The video of this session includes the following presentations:
Collateral damage: exploring antimicrobial and microbiome dynamics - Professor Lindsay Hall, Chair of Microbiome Research, University of Birmingham
Precision Antimicrobial Therapy: Integrating microbiome insights into clinical decision-making - Dr Frances Davies, Imperial College Healthcare NHS Trust
Faeces as a medicinal product for the treatment of infection? - Professor Peter Hawkey, Professor Emeritus of Clinical & Public Health Bacteriology, University of Birmingham
Q&A
Day one closing remarks
-
The video of this session includes the following presentations:
Collateral damage: exploring antimicrobial and microbiome dynamics - Professor Lindsay Hall, Chair of Microbiome Research, University of Birmingham
Precision Antimicrobial Therapy: Integrating microbiome insights into clinical decision-making - Dr Frances Davies, Imperial College Healthcare NHS Trust
Faeces as a medicinal product for the treatment of infection? - Professor Peter Hawkey, Professor Emeritus of Clinical & Public Health Bacteriology, University of Birmingham
Q&A
Day one closing remarks
SESSION EIGHT: Invited papers supported by JAC and JAC-AMR
-
The video of this session includes the following presentations:
Resistance on enteric surveillance of children is an effective predictor of resistance in Gram-negative bloodstream infections in a two-centre study - Dr Victoria Austin, Alder Hey Children’s Hospital
The economic and clinical burden of antibiotic-resistant community-acquired E. coli urinary tract infections - Emma Carter, Imperial College London
Development of AWaRe antibiotic quality indicators for optimal use - Annie Heath, City St George’s, University of London
The potential of Pyridylpiperazines efflux pump inhibitors to restore antimicrobial activity in multidrug-resistant Klebsiella pneumoniae - Cécilia Sobieski, Institut Pasteur De Lille
Q&A
SESSION NINE: Panel discussion - Antimicrobials at the End of Life: Treatment, Burden or Comfort?
-
The video of this session includes the following presentations:
Panellists:
Dr Tom Hellyer, Newcastle University
Professor Mahesh Nirmalan, University of Manchester & Hon. Consultant in Intensive Care Medicine, Manchester Royal Infirmary
Dr Aoife Gleeson, Visiting Professor, University of South Wales & Honorary Senior Lecturer, Cardiff University & Clinical Director for Palliative Medicine, Aneurin Bevan University Healthboard
SESSION TEN: Test now or treat never - the high stakes future of antimicrobial diagnostics
-
The video of this session includes the following presentations:
Fungal - Professor Lewis White, University Hospital of Wales
Bacterial - Professor Paul Dark, The University of Manchester
Viral - Professor Maria Zambon, UKHSA
Q&A
SESSION THIRTEEN: Precision treatment for Gram negative pathogens - cracking the resistance code
-
The video of this session includes the following presentations:
The resistance alphabet: decoding ESBLs, AmpCs and KPCs in clinical practice - Dr Mandy Wootton, Public Health Wales
The rise of the mutants: Navigating OXA-48 and NDM in high-risk patients - Dr Linzy Elton, University College London
The stewardship dilemma: treatment v no treatment - where to begin and end - Dr Jessica Martin, Clinical Microbiologist & Medical Lead for IPC & AMR, Leeds Teaching Hospitals Trust
Q&A
SESSION FOURTEEN: Beyond 2025 - Moving the needle
-
The video of this session includes the following presentations:
Tuberculosis - Dr Rachel Tanner, University of Oxford
Candida infection - Dr Neil Stone, University College London Hospitals & Associate Professor, UCL
Avian flu - Professor Munir Iqbal, The Pirbright Institute & Visiting Professor, Royal Veterinary College London
Q&A
Closing remarks